← Leaderboards
Jin Xie
University Of Georgia
$5,472,717
Attributed
$8,124,578
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,124,578 · 5
By mechanism
R01$6,513,087 · 3
R42$901,390 · 1
R00$710,101 · 1
Top collaborators
- Zibo Li9 shared
- William Y Kim4 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCell KillingTumorMalignant Breast NeoplasmNanoparticleTreatment EfficacyToxic EffectDiagnosisIn VitroLeadCancer TypeFormulationDosePharmaceutical PreparationsMalignant Neoplasm Of ProstateBaseCancer CellCancer PatientIn VivoSystemic ToxicityChemotherapyAppropriate DoseMalignant Neoplasm Of LungCancer Etiology
Grant awards (17)
Development of a radiation-activatable nanoparticle for lung cancer therapy$901,390
R42 · FY2025 · CA · contact PI
Development of a novel biodegradable inorganic nanoparticle therapeutic for cancer$503,511
R01 · FY2024 · CA · contact PI
The development of novel radiation-sensitizer based on ultra-small carbon dots$474,089
R01 · FY2024 · CA
Development of a novel biodegradable inorganic nanoparticle therapeutic for cancer$525,898
R01 · FY2023 · CA · contact PI
The development of novel radiation-sensitizer based on ultra-small carbon dots$489,318
R01 · FY2023 · CA
Development of a novel biodegradable inorganic nanoparticle therapeutic for cancer$531,155
R01 · FY2022 · CA · contact PI
The development of novel radiation-sensitizer based on ultra-small carbon dots$489,570
R01 · FY2022 · CA
Development of a novel biodegradable inorganic nanoparticle therapeutic for cancer$552,591
R01 · FY2021 · CA · contact PI
The development of novel radiation-sensitizer based on ultra-small carbon dots$507,058
R01 · FY2021 · CA
The development of novel radiation-sensitizer based on ultra-small carbon dots$526,148
R01 · FY2020 · CA
Nanoscintillator-based X-ray sensitizers to enable efficient NSCLC treatment with X-ray irradiation$471,199
R01 · FY2020 · EB · contact PI
Nanoscintillator-based X-ray sensitizers to enable efficient NSCLC treatment with X-ray irradiation$473,515
R01 · FY2019 · EB · contact PI
Nanoscintillator-based X-ray sensitizers to enable efficient NSCLC treatment with X-ray irradiation$476,715
R01 · FY2018 · EB · contact PI
Nanoscintillator-based X-ray sensitizers to enable efficient NSCLC treatment with X-ray irradiation$492,320
R01 · FY2017 · EB · contact PI
Nanoplatform-based combinational therapy against breast cancer$227,039
R00 · FY2013 · CA · contact PI
Nanoplatform-based combinational therapy against breast cancer$241,531
R00 · FY2012 · CA · contact PI
Nanoplatform-based combinational therapy against breast cancer$241,531
R00 · FY2011 · CA · contact PI